Clinical Trial Update: Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating CLP with and without spironolactone in heart failure patients with chronic kidney disease has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure

Drugs mentioned

• CLP
• Spironolactone (spironolactone)

Snippet

Sponsor: Sorbent Therapeutics | Conditions: Heart Failure | Phase 1 | Status: COMPLETED | Results posted: 2013-05-08